Viela Bio, Inc.
Net SellingVIE·US·🇺🇸 US
36%buys·64%sales
185 transactions$97.0MTotal buys·25 buys
$5.9BTotal sells·44 sells
2222 insiders
Last: Mar 15, 2021
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Mar 15, 21 | Yao Zhengbin | Disposition | - | |
| Mar 15, 21 | Yao Zhengbin | Disposition | - | |
| Mar 15, 21 | Yao Zhengbin | Disposition | - | |
| Mar 15, 21 | Ragatz William | Disposition | - | |
| Mar 15, 21 | Ragatz William | Disposition | - | |
| Mar 15, 21 | Ragatz William | Disposition | - | |
| Mar 15, 21 | Jacques Rachelle Suzanne | Disposition | - | |
| Mar 15, 21 | Jacques Rachelle Suzanne | Disposition | - | |
| Mar 15, 21 | Nolet Chris | Disposition | - | |
| Mar 15, 21 | Nolet Chris | Disposition | - |
Viela Bio, Inc. (VIE) has recorded 185 insider transactions from 22 insiders. Total insider buying volume stands at $97.0M, while total selling volume is $5.9B. Overall insider sentiment is bearish (64% sales).
Viela Bio, Inc. (VIE) has recorded 185 insider operations, including 25 open-market purchases ($97.0M), 44 sales ($5.9B) and 116 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (64% sales).
Recent activity is concentrated over 3 months in the last year.
Among the most active insiders are Yao Zhengbin (CEO), Chan Mitchell (CFO) & Drappa Jorn (C SUITE), with respectively 30, 20, 32 transactions.
Across all 185 recorded transactions, the breakdown by type is: exercise (74, 40%), sales (44, 24%), disposition (29, 16%), buys (25, 14%), grant (13, 7%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Viela Bio, Inc. has recorded 185 insider operations in total, including 25 open-market purchases ($97.0M), 44 sales ($5.9B) and 116 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on March 15, 2021.
Insiders at Viela Bio, Inc. are currently net sellers, with 36% purchases and 64% sales across all reported transactions. Total buy volume is $97.0M versus $5.9B in sales, indicating a bearish insider sentiment.
InsiderLens tracks 22 insiders at Viela Bio, Inc. (VIE). Yao Zhengbin (CEO, 30 tx), Chan Mitchell (CFO, 20 tx), Drappa Jorn (C SUITE, 32 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for VIE is bearish, based on a 36% buy ratio across 69 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Viela Bio, Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.